Dear Chris,

I think providing a environment that others can use is an important part of the 
provenance question.  It’s one thing to document dependencies, but in order to 
really make sure they are correct and complete you need to test them in a 
compute environment.  https://mybinder.org/ is a great and free example of this 
setup.  If you provide dependencies in standard text files, everyone can re-run 
your results (in python, R, others) in a virtual compute environment. Showing 
researchers the benefits of capturing provenance information is an important 
part of driving adoption.

Best,

Tom Morrell
Research Data Specialist, Caltech Library

On Aug 13, 2018, at 6:36 AM, Chris Gates 
<[email protected]<mailto:[email protected]>> wrote:

This is a wonderful thread and thanks to all. In bioinformatics, the web of 
dependencies is so dense and brittle, that beyond provenance there is 
increasing interest in sharing compute environments in a reproducible way using 
automated workflow frameworks and virtualization/containerization. In effect, 
the downstream users saying "please document your provenance - and (since I'm 
too impatient to read it) also please gather dependent data/programs/workflows 
into a an environment that I would actually use". This idea is, of course, 
distinct from provenance per se, so I don't want to muddy this thread - but it 
seems related, and worth mentioning.

Best,
cg
The Carpentries<https://carpentries.topicbox.com/latest> / discuss / see 
discussions<https://carpentries.topicbox.com/groups/discuss> + 
participants<https://carpentries.topicbox.com/groups/discuss/members> + 
delivery options<https://carpentries.topicbox.com/groups/discuss/subscription> 
Permalink<https://carpentries.topicbox.com/groups/discuss/Te1cade367c0ab4ee-M533110c2162c11fb5ef71048>

------------------------------------------
The Carpentries: discuss
Permalink: 
https://carpentries.topicbox.com/groups/discuss/Te1cade367c0ab4ee-M56d1de7821704659d5f162e5
Delivery options: https://carpentries.topicbox.com/groups/discuss/subscription

Reply via email to